F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuroradiology

• Publication date

  2011-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00234-011-0898-3PMID 21739222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain tumors

  2005cited by this paper
• A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

  2005cited by this paper
• Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

  2004cited by this paper
• A Systematic Overview of Radiation Therapy Effects in Brain Tumours

  2003cited by this paper
• The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery

  2001cited by this paper
• Brain tumors.

  2001cited by this paper
• Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning.

  2001cited by this paper
• PET in differentiation of recurrent brain tumor from radiation injury.

  2000cited by this paper
• Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

  2000cited by this paper
• Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study

  1999cited by this paper
• Primary and secondary glioblastomas: from concept to clinical diagnosis.

  1999cited by this paper
• Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.

  1999cited by this paper
• Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells.

  1999cited by this paper
• Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy

  1999cited by this paper
• Imaging of adult brain tumors.

  1999influential reference
• The practical management of low-grade primary brain tumors

  1999cited by this paper
• 11C-methionine PET for differential diagnosis of low-grade gliomas

  1998cited by this paper
• Survival and functional status after resection of recurrent glioblastoma multiforme.

  1998cited by this paper
• Positron emission tomography and brain tumours.

  1997cited by this paper
• Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

  1997cited by this paper
• Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.

  1996cited by this paper
• Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography‐guided stereotactic biopsy

  1996cited by this paper
• Survivor Treatment Selection Bias in Observational Studies: Examples from the AIDS Literature

  1996cited by this paper
• Analysis of the relationship between long-term operative success and a transient or delayed operative side effect.

  1996cited by this paper
• Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.

  1996cited by this paper
• Logical and statistical fallacies in the use of Cox regression models.

  1996cited by this paper
• Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

  1994cited by this paper
• Glucose consumption in recurrent gliomas.

  1993cited by this paper
• Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors

  1993cited by this paper
• Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.

  1992cited by this paper
• Treatment and survival of low-grade astrocytoma in adults--1977-1988.

  1992cited by this paper
• Positron emission tomography in patients with glioma a predictor of prognosis

  1988cited by this paper
• Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

  1987cited by this paper
• Prediction of survival in glioma patients by means of positron emission tomography.

  1985influential reference
• Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

  1982cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper

• Potential of Preoperative 11C-Methionine Positron Emission Tomography in Predicting EGFR Alterations and CDKN2A/B Homozygous Deletion in Diffuse Astrocytic Gliomas

  2025cites this paper
• Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies

  2025cites this paper
• Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas

  2024cites this paper
• PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach

  2023cites this paper
• Standard clinical approaches and emerging modalities for glioblastoma imaging

  2022cites this paper
• Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients

  2022cites this paper
• Early Recurrence Detection of Glioma Using 18F-Fluorocholine PET/CT

  2022cites this paper
• Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging.

  2021cites this paper
• Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

  2020cites this paper
• Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma.

  2019cites this paper
• A Non-invasive Radiomic Method Using 18F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma

  2019cites this paper
• Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma

  2019cites this paper
• 18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

  2019cites this paper
• Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis

  2018cites this paper
• Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma

  2018cites this paper
• The Added Prognostic Value of Metabolic Tumor Size on FDG‐PET at First Suspected Recurrence of Glioblastoma Multiforme

  2017cites this paper
• Brain Tumors: An Update on Clinical PET Research in Gliomas.

  2017cites this paper
• Diagnostic Applications of Nuclear Medicine: Brain Tumors

  2016cites this paper
• ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.

  2015cites this paper
• The role of neuropathology in the management of patients with diffuse low grade glioma

  2015cites this paper
• Imaging of brain tumours

  2015cites this paper
• Letter: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?

  2015cites this paper
• The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.

  2015cites this paper
• The role of imaging in the management of adults with diffuse low grade glioma

  2015cites this paper
• In reply: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?

  2015cites this paper
• Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.

  2015cites this paper
• Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study

  2015cites this paper
• 11C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas

  2014cites this paper
• 68Ga-PRGD2 PET/CT in the Evaluation of Glioma: A Prospective Study

  2014cites this paper
• Functional Imaging of Malignant Gliomas with CT Perfusion

  2014cites this paper
• Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT

  2014cites this paper
• Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.

  2014cites this paper
• Relationship of computed tomography perfusion and positron emission tomography to tumour progression in malignant glioma

  2014cites this paper
• Kinetic analysis of 2-([(18)F]fluoro)-2-deoxy-d-glucose uptake in brains of anesthetized healthy dogs.

  2014cites this paper
• Positron emission tomography imaging in gliomas

  2014cites this paper
• Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.

  2014cites this paper
• Glioblastoma multiforme imaging: the role of nuclear medicine.

  2012cites this paper
• Kinetic analysis of 2-([ 18 F]fluoro)-2-deoxy- D -glucose uptake in brains of anesthetized healthy dogs

  year unknowncites this paper